Comparison

CASP vs Hepatocellular Carcinoma

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

CASP

Critically appraise medical literature using evidence-based templates. Includes a glossary, calculators for NNT and post-test probability, and the ability to save and share appraisals.

Highlights
  • Critical appraisal templates
  • Glossary of terms
  • NNT calculator
  • Post-Test Probability calculator
  • Save and share appraisals
  • PDF export
Features
Read full description

CASP offers a convenient way to critically apprais the medical literature, it is based in CASP (Critical Appraisal Skills Programme) templates. And incorporates a Glossary section, and NNT and Post-Test Probability calculators with interpretation of the results. It allows to save and share critical appraisals in CASP and PDF formats.

About

Hepatocellular Carcinoma

Features
Read full description

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Hepatocellular Carcinoma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Hepatocellular Carcinoma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Hepatocellular Carcinoma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

Screenshots

CASP2 screens
Hepatocellular Carcinoma4 screens

Verdict

The call

The clearest difference is iOS requirement: CASP at 7.0 against Hepatocellular Carcinoma's 14.0. On price, update cadence, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on November 1, 2026 and November 11, 2026 respectively.

Scorecard1 real difference · 9 level
CASP versus Hepatocellular Carcinoma: the parameters behind the verdict, then further details
ParameterCASPHepatocellular Carcinoma
PriceFreeFree
Rating2.5 (2 ratings) — better—
Positive reviews100.0% of reviews—
Number of ratings2 — better—
Update frequencyEvery 2 monthsEvery 2 months
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS7.0 — better14.0
Further details — not scored
Size2 MB23 MB
Age rating4+12+
DeveloperLuis Ruiz del Fresno@Point of Care

In-app purchases

None

CASP

No in-app purchases

None

Hepatocellular Carcinoma

No in-app purchases

Questions

Is CASP free?
CASP is free to download, with no in-app purchases.
Is Hepatocellular Carcinoma free?
Hepatocellular Carcinoma is free to download, with no in-app purchases.
Do CASP or Hepatocellular Carcinoma have ads?
Neither CASP nor Hepatocellular Carcinoma shows ads.
Which is updated more often, CASP or Hepatocellular Carcinoma?
CASP ships an update every 2 months, and Hepatocellular Carcinoma every 2 months. Most recently, CASP was updated on November 1, 2026 and Hepatocellular Carcinoma on November 11, 2026.

Other comparisons